デフォルト表紙
市場調査レポート
商品コード
1483051

迅速検査の世界市場(2024年~2031年)

Global Rapid Test Market 2024-2031

出版日: | 発行: Orion Market Research | ページ情報: 英文 190 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=159.16円
迅速検査の世界市場(2024年~2031年)
出版日: 2024年03月22日
発行: Orion Market Research
ページ情報: 英文 190 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の迅速検査の市場規模は、予測期間(2024年~2031年)に8.2%のCAGRで成長すると予測されています。 疾病の早期かつ確実な診断に関する意識の高まり、感染症の流行、技術的に進歩した製品の導入、低コストかつ正確な診断検査へのニーズなどが背景にあります。その他の利点として、迅速検査は短時間で正確な結果が得られるため、ポイント・オブ・ケア検査における迅速検査の採用が急増しており、即日結果が得られることが市場の成長を後押ししています。

セグメント別展望

感染症サブセグメントが世界の迅速検査市場でかなりのシェアを占めると予測される

用途別では、感染症サブセグメントが世界の迅速検査市場でかなりのシェアを占めると予想されます。COVID-19は迅速診断市場にプラスの影響を与えました。例えば、2021年4月、ドイツ連邦政府は、ドイツ国内の雇用主に対し、在宅勤務のみでない全従業員にCOVID-19自己検査キットを無料で提供することを義務化しました。さらに2022年3月、非営利研究機関ブレイン・ケミストリー・ラボとアーリントン・サイエンティフィックは、使いやすい迅速検査キットの開発を発表しました。このキットは、筋萎縮性側索硬化症(ALS)と呼ばれる致命的な麻痺性疾患を引き起こすシアノバクテリアの毒素であるB-メチルアミノ-L-アラニン(BMAA)の存在を検出します。したがって、このような新興国市場の開拓により、迅速診断アッセイの普及はさらに進み、市場成長を牽引すると予想されます。世界保健機関(WHO)によると、2010年~2020年に、マラリア用の迅速診断検査(RDT)は全世界で31億個がメーカーにより販売され、そのほぼ81%がサハラ以南のアフリカ諸国で販売されています。同期間に、国家マラリア計画(NMP)は22億個のRDTを配布しました。2020年には、4億1,900万個のRDTが製造業者によって販売され、2億7,500万個がNMPによって配布されました。2020年には、世界で推定2億4,100万人のマラリア患者と62万7,000人のマラリア死亡者が発生しました。これは、2019年と比較して2020年の感染者数が約1,400万人増加し、死亡者数が6万9,000人増加したことを意味します。

地域別展望

世界の迅速検査市場は、北米(米国、カナダ)、欧州(英国、イタリア、スペイン、ドイツ、フランス、その他欧州)、アジア太平洋(インド、中国、日本、韓国、その他アジア太平洋)、世界のその他の地域(中東とアフリカ、ラテンアメリカ)を含む地域によってさらに細分化されます。中でもアジア太平洋は、可処分所得の増加、高い人口基盤、事前迅速検査に関する認知度の向上により、世界全体で大きなシェアを占めると予想されています。さらに、インドや中国などの新興国市場における研究開発費の増加により、迅速検査市場は成長しています。

北米は世界の迅速検査市場で大きなCAGRで成長する見込み

すべての地域の中で、北米は予測期間中にかなりのCAGRで成長すると予測されています。慢性疾患や感染症の有病率の高さ、感染症の研究や診断への投資の高さ、市場企業の最近の開発。これとは別に、効果的なヘルスケアソリューションを提供するための病院や専門クリニックの建設が増加しています。また、大衆のヘルスケア支出の増加が市場の成長に寄与しています。がんなどの病気は、早期に診断されれば容易に治療できます。がんの早期発見は、治療が成功する確率を高めます。がんの早期診断に対する多くの障害は、この迅速で手頃な価格の検査によって解決される可能性があります。特に、特定の臓器をターゲットとする調査につながるような特定の症状を持たない患者においてはそうです。アメリカがん協会によると、2022年には1,800万人以上のアメリカ人ががんに罹患していると報告されています。また、2023年には米国で新たに190万人以上ががんと診断されると推定されています。

北米におけるHIV診断の増加は、迅速検査キットの使用増加にもつながっています。迅速HIV自己検査は、口から採取した液体を用いてHIVに対する抗体を調べるものです。食品医薬品局(FDA)によると、家庭用HIV検査キットOraQuickのHIV検出精度は約92%です。HIVに感染していないのに陽性と判定される人は、5,000人に1人程度です。2021年の新規HIV診断の79%を占め、引き続き男性がHIVの影響を大きく受けています。

米国における13歳以上のHIV診断の男女差(2021年)

目次

第1章 レポート概要

  • 業界の現状分析と成長ポテンシャルの展望
  • 調査方法とツール
  • 市場内訳
    • セグメント別
    • 地域別

第2章 市場概要と洞察

  • 調査範囲
  • アナリストの洞察と現在の市場動向
    • 主な調査結果
    • 推奨事項
    • 結論

第3章 競合情勢

  • 主要企業分析
  • Abbott Laboratories
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • ACON Laboratories, Inc.
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • Becton, Dickinson and Company
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • Thermo Fisher Scientific Inc.
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • 主要戦略分析

第4章 市場セグメンテーション

  • 迅速検査の世界市場:製品別
    • ラボ用迅速検査
    • 一般用迅速検査薬
  • 迅速検査の世界市場:技術別
    • 粉末免疫測定法
    • クロマトグラフィー
    • 分光法
    • ポリメラーゼ連鎖反応(PCR)
  • 迅速検査の世界市場:用途別
    • 感染症
    • 妊娠検査
    • グルコース検査
    • その他(コレステロール検査、糖尿病検査)
  • 迅速検査の世界市場:エンドユーザー別
    • 病院・クリニック
    • 診断研究所
    • 在宅ケア

第5章 地域別分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
  • その他アジア太平洋
  • 世界のその他の地域

第6章 企業プロファイル

  • Alfa Scientific Designs Inc.
  • Artron Laboratories Inc
  • BioMerieux
  • BTNX Inc.
  • Cenogenics Corporation
  • Cepheid
  • Danaher Corporation
  • DiaSorin S.p.A
  • F. Hoffmann-La Roche Ltd
  • HemoCue America
  • Hologic, Inc.
  • Meridian Bioscience, Inc.
  • NuLife
  • OraSure Technologies, Inc.
  • Siemens Healthcare GmbH
図表

LIST OF TABLES

  • 1.GLOBAL RAPID TEST MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2023-2031 ($ MILLION)
  • 2.GLOBAL LABORATORY RAPID TEST MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 3.GLOBAL OVER-THE-COUNTER RAPID TEST MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 4.GLOBAL RAPID TEST MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2023-2031 ($ MILLION)
  • 5.GLOBAL IMMUNOASSAY RAPID TEST MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 6.GLOBAL CHROMATOGRAPHY RAPID TEST MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 7.GLOBAL SPECTROSCOPY RAPID TEST MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 8.GLOBAL PCR RAPID TEST MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 9.GLOBAL RAPID TEST MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2023-2031 ($ MILLION)
  • 10.GLOBAL RAPID TEST FOR INFECTIOUS DISEASE MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 11.GLOBAL RAPID TEST FOR PREGNANCY MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 12.GLOBAL RAPID TEST FOR GLUCOSE MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 13.GLOBAL RAPID TEST FOR OTHER APPLICATIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 14.GLOBAL RAPID TEST MARKET RESEARCH AND ANALYSIS BY END-USERS, 2023-2031 ($ MILLION)
  • 15.GLOBAL RAPID TEST FOR HOSPITALS & CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 16.GLOBAL RAPID TEST FOR DIAGNOSTIC LABORATORIES MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 17.GLOBAL RAPID TEST FOR HOME CARE MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 18.GLOBAL RAPID TEST MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 19.NORTH AMERICAN RAPID TEST MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2023-2031 ($ MILLION)
  • 20.NORTH AMERICAN RAPID TEST MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2023-2031 ($ MILLION)
  • 21.NORTH AMERICAN RAPID TEST MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2023-2031 ($ MILLION)
  • 22.NORTH AMERICAN RAPID TEST MARKET RESEARCH AND ANALYSIS BY APPLICATION INDUSTRY, 2023-2031 ($ MILLION)
  • 23.NORTH AMERICAN RAPID TEST MARKET RESEARCH AND ANALYSIS BY END-USERS, 2023-2031 ($ MILLION)
  • 24.EUROPEAN RAPID TEST MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2023-2031 ($ MILLION)
  • 25.EUROPEAN RAPID TEST MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2023-2031 ($ MILLION)
  • 26.EUROPEAN RAPID TEST MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2023-2031 ($ MILLION)
  • 27.EUROPEAN RAPID TEST MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2023-2031 ($ MILLION)
  • 28.EUROPEAN RAPID TEST MARKET RESEARCH AND ANALYSIS BY END-USERS, 2023-2031 ($ MILLION)
  • 29.ASIA-PACIFIC RAPID TEST MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2023-2031 ($ MILLION)
  • 30.ASIA-PACIFIC RAPID TEST MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2023-2031 ($ MILLION)
  • 31.ASIA-PACIFIC RAPID TEST MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2023-2031 ($ MILLION)
  • 32.ASIA-PACIFIC RAPID TEST MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2023-2031 ($ MILLION)
  • 33.ASIA- PACIFIC RAPID TEST MARKET RESEARCH AND ANALYSIS BY END-USERS, 2023-2031 ($ MILLION)
  • 34.REST OF THE WORLD RAPID TEST MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 35.REST OF THE WORLD RAPID TEST MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2023-2031 ($ MILLION)
  • 36.REST OF THE WORLD RAPID TEST MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2023-2031 ($ MILLION)
  • 37.REST OF THE WORLD RAPID TEST MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2023-2031 ($ MILLION)
  • 38.REST OF THE WORLD TEST MARKET RESEARCH AND ANALYSIS BY END-USERS, 2023-2031 ($ MILLION)

LIST OF FIGURES

  • 1.GLOBAL RAPID TEST MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2023 VS 2031 (%)
  • 2.GLOBAL LABORATORY RAPID TEST MARKET RESEARCH AND ANALYSIS BY REGION, 2023 VS 2031 (%)
  • 3.GLOBAL OVER-THE-COUNTER RAPID TEST MARKET RESEARCH AND ANALYSIS BY REGION, 2023 VS 2031 (%)
  • 4.GLOBAL RAPID TEST MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2023 VS 2031 (%)
  • 5.GLOBAL IMMUNOASSAY RAPID TEST MARKET RESEARCH AND ANALYSIS BY REGION, 2023 VS 2031 (%)
  • 6.GLOBAL CHROMATOGRAPHY RAPID TEST GRAINS MARKET RESEARCH AND ANALYSIS BY REGION, 2023 VS 2031 (%)
  • 7.GLOBAL SPECTROSCOPY RAPID TEST MARKET RESEARCH AND ANALYSIS BY REGION, 2023 VS 2031 (%)
  • 8.GLOBAL PCR RAPID TEST MARKET RESEARCH AND ANALYSIS BY REGION, 2023 VS 2031 (%)
  • 9.GLOBAL RAPID TEST MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2023 VS 2031 (%)
  • 10.GLOBAL RAPID TEST FOR INFECTIOUS DISEASE MARKET RESEARCH AND ANALYSIS BY REGION, 2023 VS 2031 (%)
  • 11.GLOBAL RAPID TEST FOR PREGNANCY MARKET RESEARCH AND ANALYSIS BY REGION, 2023 VS 2031 (%)
  • 12.GLOBAL RAPID TEST FOR GLUCOSE MARKET RESEARCH AND ANALYSIS BY REGION, 2023 VS 2031 (%)
  • 13.GLOBAL RAPID TEST FOR OTHER APPLICATIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2023 VS 2031 (%)
  • 14.GLOBAL RAPID TEST MARKET RESEARCH AND ANALYSIS BY END-USERS, 2023 VS 2031 (%)
  • 15.GLOBAL RAPID TEST FOR HOSPITALS & CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2023 VS 2031 (%)
  • 16.GLOBAL RAPID TEST FOR DIAGNOSTIC LABORATORIES MARKET RESEARCH AND ANALYSIS BY REGION, 2023 VS 2031 (%)
  • 17.GLOBAL RAPID TEST FOR HOME CARE MARKET RESEARCH AND ANALYSIS BY REGION, 2023 VS 2031 (%)
  • 18.GLOBAL RAPID TEST MARKET RESEARCH AND ANALYSIS BY REGION, 2023 VS 2031 (%)
  • 19.US RAPID TEST MARKET SIZE, 2023-2031 ($ MILLION)
  • 20.CANADA RAPID TEST MARKET SIZE, 2023-2031 ($ MILLION)
  • 21.UK RAPID TEST MARKET SIZE, 2023-2031 ($ MILLION)
  • 22.FRANCE RAPID TEST MARKET SIZE, 2023-2031 ($ MILLION)
  • 23.GERMANY RAPID TEST MARKET SIZE, 2023-2031 ($ MILLION)
  • 24.ITALY RAPID TEST MARKET SIZE, 2023-2031 ($ MILLION)
  • 25.SPAIN RAPID TEST MARKET SIZE, 2023-2031 ($ MILLION)
  • 26.REST OF EUROPE RAPID TEST MARKET SIZE, 2023-2031 ($ MILLION)
  • 27.INDIA RAPID TEST MARKET SIZE, 2023-2031 ($ MILLION)
  • 28.CHINA RAPID TEST MARKET SIZE, 2023-2031 ($ MILLION)
  • 29.JAPAN RAPID TEST MARKET SIZE, 2023-2031 ($ MILLION)
  • 30.SOUTH KOREA RAPID TEST MARKET SIZE, 2023-2031 ($ MILLION)
  • 31.REST OF ASIA-PACIFIC RAPID TEST MARKET SIZE, 2023-2031 ($ MILLION)
  • 32.LATIN AMERICA RAPID TEST MARKET SIZE, 2023-2031 ($ MILLION)
  • 33.THE MIDDLE EAST & AFRICA RAPID TEST MARKET SIZE, 2023-2031 ($ MILLION)
目次
Product Code: OMR2028228

Rapid Test Market Size, Share & Trends Analysis Report by Product (Laboratory Rapid Test and Over-the-counter (OTC) Rapid Test), by Technology (Immunoassay, Chromatography, Spectroscopy, and Polymerase Chain Reaction (PCR)), by Application (Infectious Disease, Pregnancy Test, Glucose Test, and Others), and by End-Users (Hospitals and Clinics, Diagnostic Laboratories, and Home Care), Forecast Period (2024-2031)

Rapid test market is anticipated to grow at a CAGR of 8.2% during the forecast period (2024-2031). The rising awareness regarding early and reliable diagnosis of disease, prevalence of infectious diseases, introduction of technologically advanced products and need for low cost as well as accurate diagnostic testing. Additionally, rapid tests provide accurate results in a short time and these benefits have led to a surge in adoption of rapid tests in point-of-care testing, wherein results are obtained on the same day which is boosting the market growth.

Segmental Outlook

The global rapid test market is segmented by the product, technology, application, and end-users. Based on the product, the market is sub-segmented into laboratory rapid test and over-the-counter rapid test products. Based on the technology, the market is sub-segmented into immunoassay, chromatography, spectroscopy, and polymerase chain reaction. Based on the application, the market is sub-segmented into infectious disease, pregnancy test, glucose test and others. Further, based on end-users, the market is sub-segmented into hospitals and clinics, diagnostic laboratories, and home care. Among the product, the laboratory rapid test sub-segment is anticipated to hold a considerable share of the market. Rapid laboratory testing can be done at the site of care, which includes clinics, hospitals, and medical offices. They are perfect for bulk population testing because they are affordable and easy to use.

The Infectious Disease Sub-Segment is Anticipated to Hold a Considerable Share of the Global Rapid test Market

Among the application, the infectious disease sub-segment is expected to hold a considerable share of the global rapid test market. The COVID-19 positively impacted the rapid diagnostics market. For instance, in April 2021, the Federal Government of Germany made it mandatory for employers in Germany to offer free COVID-19 self-testing kits to all employees who do not exclusively work from home. Furthermore, in March 2022, Brain Chemistry Labs, a non-profit research institute, and Arlington Scientific, announced the development of an easy-to-use rapid test kit. This kit will detect the presence of B-methylamino-L-Alanine (BMAA), a toxin in cyanobacterial blooms, which causes a fatal paralytic disease called Amyotrophic Lateral Sclerosis (ALS). Thus, such developments, the penetration of rapid diagnostic assays is expected to increase further, driving the market's growth. According to the World Health Organization (WHO), globally, 3.1 billion rapid diagnostic tests (RDTs) for malaria were sold by manufacturers in 2010-2020, with almost 81% of these sales being in sub-Saharan African countries. In the same period, National Malaria Programme (NMPs) distributed 2.2 billion RDT. In 2020, 419 million RDTs were sold by manufacturers and 275 million were distributed by NMPs. There were an estimated 241 million malaria cases and 627,000 malaria deaths globally in 2020. This represents about 14 million more cases in 2020 compared to 2019, and 69000 more deaths.

Regional Outlook

The global Rapid test market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Asia-Pacific is anticipated to hold a prominent share of the market across the globe, owing to increase in disposable incomes, high population base, and growth in awareness about advance rapid tests. Additionally, the rapid test market is growing due to an increase in R&D spending in developing nations such as India, and China.

Global Rapid Test Market Growth, by Region 2024-2031

Source: OMR Analysis

The North America Region is Expected to Grow at a Significant CAGR in the Global Rapid test Market

Among all regions, the North American region is anticipated to grow at a considerable CAGR over the forecast period. The high prevalence of chronic and infectious diseases, high investments in the research and diagnosis of infectious diseases and recent development by the market players. Apart from this rising construction of hospitals and specialized clinics to offer effective healthcare solutions. And increasing healthcare expenditure among the masses is contributing to the growth of the market. Disease such as cancer if diagnosed early can be treated easily. Early cancer detection increases the probability of successful treatment. Many obstacles to the early diagnosis of cancer may be addressed by this quick and affordable test, particularly in patients who do not have specific symptoms that lead research to target a particular organ. According to American Cancer Society, over 18 million Americans were reported to have cancer in 2022. They stated that over 1.9 million new cancer cases are estimated to be diagnosed in the US in 2023.

The rise in HIV diagnosis in North America has also led to an increase in use of rapid test kits. A rapid HIV self-test uses a sample of fluid from mouth to check for antibodies to HIV. According to the Food and Drug Administration (FDA), the OraQuick in-home HIV test measured at about 92 percent accuracy at detecting HIV. About 1 out of 5,000 people test positive when they don't have HIV. Men continue to be heavily affected by HIV, accounting for 79% of new HIV diagnoses in 2021.

Differences in HIV Diagnoses by Gender in US, among people aged 13 and older, 2021

Source: Centers for Disease Control and Prevention (CDC)

Market Players Outlook

The major companies serving the global rapid test market include Thermo Fisher Scientific Inc., ACON Laboratories, Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd, Alfa Scientific Designs Inc., Becton, Dickinson and Company, and BioMerieux, among others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in August 2022, Becton, Dickinson and Co. (BD) Accelerate Diagnostics, announced commercial collaboration. Under the collaboration, BD will provide Accelerate's rapid testing solutions for antibiotic resistance and susceptibility. The tests are said to provide results within hours, while traditional laboratory methods take one to two days for results. BD will market the Accelerate Pheno system and Accelerate Arc module and related test kits through its global network, where the products have been approved for use.

The Report Covers:

  • Market value data analysis of 2023 and forecast to 2031.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global rapid test market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1.Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1.Research Methods and Tools
  • 1.2.Market Breakdown
    • 1.2.1.By Segments
    • 1.2.2.By Region

2.Market Overview and Insights

  • 2.1.Scope of the Report
  • 2.2.Analyst Insight & Current Market Trends
    • 2.2.1.Key Findings
    • 2.2.2.Recommendations
    • 2.2.3.Conclusion

3.Competitive Landscape

  • 3.1.Key Company Analysis
  • 3.2.Abbott Laboratories
    • 3.2.1.Overview
    • 3.2.2.Financial Analysis
    • 3.2.3.SWOT Analysis
    • 3.2.4.Recent Developments
  • 3.3.ACON Laboratories, Inc.
    • 3.3.1.Overview
    • 3.3.2.Financial Analysis
    • 3.3.3.SWOT Analysis
    • 3.3.4.Recent Developments
  • 3.4.Becton, Dickinson and Company
    • 3.4.1.Overview
    • 3.4.2.Financial Analysis
    • 3.4.3.SWOT Analysis
    • 3.4.4.Recent Developments
  • 3.5.Thermo Fisher Scientific Inc.
    • 3.5.1.Overview
    • 3.5.2.Financial Analysis
    • 3.5.3.SWOT Analysis
    • 3.5.4.Recent Developments
  • 3.6.Key Strategy Analysis

4.Market Segmentation

  • 4.1.Global Rapid Test Market by Product
    • 4.1.1.Laboratory Rapid Test
    • 4.1.2.Over-the-Counter (OTC) Rapid Test
  • 4.2.Global Rapid Test Market by Technology
    • 4.2.1.Powder Immunoassay
    • 4.2.2.Chromatography
    • 4.2.3.Spectroscopy
    • 4.2.4.Polymerase Chain Reaction (PCR)
  • 4.3.Global Rapid Test Market by Application
    • 4.3.1.Infectious Disease
    • 4.3.2.Pregnancy Test
    • 4.3.3.Glucose Test
    • 4.3.4.Others (Cholesterol Test, Diabetes)
  • 4.4.Global Rapid Test Market by End-Users
    • 4.4.1.Hospitals & Clinics
    • 4.4.2.Diagnostic Laboratories
    • 4.4.3.Home Care

5.Regional Analysis

  • 5.1.North America
    • 5.1.1.United States
    • 5.1.2.Canada
  • 5.2.Europe
    • 5.2.1.UK
    • 5.2.2.Germany
    • 5.2.3.Italy
    • 5.2.4.Spain
    • 5.2.5.France
    • 5.2.6.Rest of Europe
  • 5.3.Asia-Pacific
    • 5.3.1.China
    • 5.3.2.India
    • 5.3.3.Japan
    • 5.3.4.South Korea
  • 5.4.Rest of Asia-Pacific
  • 5.5.Rest of the World

6.Company Profiles

  • 6.1.Alfa Scientific Designs Inc.
  • 6.2.Artron Laboratories Inc
  • 6.3.BioMerieux
  • 6.4.BTNX Inc.
  • 6.5.Cenogenics Corporation
  • 6.6.Cepheid
  • 6.7.Danaher Corporation
  • 6.8.DiaSorin S.p.A
  • 6.9.F. Hoffmann-La Roche Ltd
  • 6.10.HemoCue America
  • 6.11.Hologic, Inc.
  • 6.12.Meridian Bioscience, Inc.
  • 6.13.NuLife
  • 6.14.OraSure Technologies, Inc.
  • 6.15.Siemens Healthcare GmbH